These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 9698288)
1. The pharmacokinetics of a new antiglaucoma drug, latanoprost, in the rabbit. Sjöquist B; Basu S; Byding P; Bergh K; Stjernschantz J Drug Metab Dispos; 1998 Aug; 26(8):745-54. PubMed ID: 9698288 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of latanoprost in the cynomolgus monkey. 3rd communication: tissue distribution after topical administration on the eye studied by whole body autoradiography. Glaucoma Research Laboratories. Sjöquist B; Johansson A; Stjernschantz J Arzneimittelforschung; 1999 Mar; 49(3):240-9. PubMed ID: 10219468 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of latanoprost in the cynomolgus monkey. 1st communication: single intravenous, oral or topical administration on the eye. Sjöquist B; Tajallaei S; Stjernschantz J Arzneimittelforschung; 1999 Mar; 49(3):225-33. PubMed ID: 10219466 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of latanoprost in the cynomolgus monkey. 2nd communication: repeated topical administration on the eye. Sjöquist B; Uhlin A; Byding P; Stjernschantz J Arzneimittelforschung; 1999 Mar; 49(3):234-9. PubMed ID: 10219467 [TBL] [Abstract][Full Text] [Related]
5. Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rats. Fukano Y; Kawazu K Drug Metab Dispos; 2009 Aug; 37(8):1622-34. PubMed ID: 19477946 [TBL] [Abstract][Full Text] [Related]
6. Ocular and systemic pharmacokinetics of latanoprost in humans. Sjöquist B; Stjernschantz J Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S6-12. PubMed ID: 12204697 [TBL] [Abstract][Full Text] [Related]
7. Ocular absorption, distribution, and systemic absorption of a novel antiglaucoma medication, prostaglandin derivative, in male white rabbits. Higaki K; Kamata K; Takeuchi M; Inazawa K; Chikai T; Hamaguchi T; Yukawa T; Kadono K; Kawahara S; Nakano M Drug Metab Dispos; 1995 Jan; 23(1):35-43. PubMed ID: 7720522 [TBL] [Abstract][Full Text] [Related]
8. Comparison of human ocular distribution of bimatoprost and latanoprost. Ichhpujani P; Katz LJ; Hollo G; Shields CL; Shields JA; Marr B; Eagle R; Alvim H; Wizov SS; Acheampong A; Chen J; Wheeler LA J Ocul Pharmacol Ther; 2012 Apr; 28(2):134-45. PubMed ID: 22136089 [TBL] [Abstract][Full Text] [Related]
9. Ocular distribution of difluprednate ophthalmic emulsion 0.05% in rabbits. Tajika T; Isowaki A; Sakaki H J Ocul Pharmacol Ther; 2011 Feb; 27(1):43-9. PubMed ID: 21118027 [TBL] [Abstract][Full Text] [Related]
10. Comparative ocular pharmacokinetics of brimonidine after a single dose application to the eyes of albino and pigmented rabbits. Acheampong AA; Shackleton M; Tang-Liu DD Drug Metab Dispos; 1995 Jul; 23(7):708-12. PubMed ID: 7587958 [TBL] [Abstract][Full Text] [Related]
11. Development of latanoprost-loaded biodegradable nanosheet as a new drug delivery system for glaucoma. Kashiwagi K; Ito K; Haniuda H; Ohtsubo S; Takeoka S Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5629-37. PubMed ID: 23868986 [TBL] [Abstract][Full Text] [Related]
12. Ocular pharmacokinetics and availability of topically applied baicalein in rabbits. Zhang L; Zhang J; Wang L; Xia H Curr Eye Res; 2009 Apr; 34(4):257-63. PubMed ID: 19373573 [TBL] [Abstract][Full Text] [Related]
13. Microvascular effects of selective prostaglandin analogues in the eye with special reference to latanoprost and glaucoma treatment. Stjernschantz J; Selén G; Astin M; Resul B Prog Retin Eye Res; 2000 Jul; 19(4):459-96. PubMed ID: 10785618 [TBL] [Abstract][Full Text] [Related]
14. The ocular pharmacokinetics of eicosanoids and their derivatives. 1. Comparison of ocular eicosanoid penetration and distribution following the topical application of PGF2 alpha, PGF2 alpha-1-methyl ester, and PGF2 alpha-1-isopropyl ester. Bito LZ; Baroody RA Exp Eye Res; 1987 Feb; 44(2):217-26. PubMed ID: 3472899 [TBL] [Abstract][Full Text] [Related]
15. Iontophoresis of vidarabine monophosphate into rabbit eyes. Hill JM; Park NH; Gangarosa LP; Hull DS; Tuggle CL; Bowman K; Green K Invest Ophthalmol Vis Sci; 1978 May; 17(5):473-6. PubMed ID: 640794 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of falintolol II. Absorption, distribution and elimination from tissues and organs following ocular administration and intravenous injection of falintolol in albino rabbits. Andermann G; Guggenbuhl P; de Burlet G; Himber J Methods Find Exp Clin Pharmacol; 1989 Dec; 11(12):747-54. PubMed ID: 2576299 [TBL] [Abstract][Full Text] [Related]
17. Metabolism and ocular tissue distribution of an antiglaucoma prostanoid, tafluprost, after ocular instillation to monkeys. Fukano Y; Kawazu K; Akaishi T; Bezwada P; Pellinen P J Ocul Pharmacol Ther; 2011 Jun; 27(3):251-9. PubMed ID: 21491995 [TBL] [Abstract][Full Text] [Related]
18. Bioavailability in the human eye of a fixed combination of latanoprost and timolol compared to monotherapy. Calissendorff B; Sjöquist B; Högberg G; Grunge-Lowerud A J Ocul Pharmacol Ther; 2002 Apr; 18(2):127-31. PubMed ID: 12002666 [TBL] [Abstract][Full Text] [Related]
19. Effect of 15-keto latanoprost on intraocular pressure and aqueous humor dynamics in monkey eyes. Wang RF; Gagliuso DJ; Mittag TW; Podos SM Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4143-7. PubMed ID: 17724199 [TBL] [Abstract][Full Text] [Related]